# Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine

> **NCT07263295** · NA · NOT_YET_RECRUITING · sponsor: **Zhejiang University** · enrollment: 120 (estimated)

## Conditions studied

- Diaphragmatic Function
- Metacarpal Fracture
- Radius Fracture
- Peripheral Nerve Neurolysis
- Chronic Ulcer
- Upper Extremity Ligament Injury

## Interventions

- **DRUG:** 0.5% Hydrochloride Bupivacaine 20ml
- **DRUG:** 0.5% Hydrochloride Bupivacaine 10ml
- **DRUG:** Liposomal Bupivacaine 10mL

## Key facts

- **NCT ID:** NCT07263295
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-05
- **Primary completion:** 2026-09-20
- **Final completion:** 2026-12-20
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07263295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07263295, "Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07263295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*